Intercarpal Joint lameness Treatment

7 Year old Warmblood-Thoroughbred Cross Gelding:

Elmo was a 7-year-old Warmblood-Thoroughbred cross gelding competing at the height of 1.4m in Showjumping. Over 12 weeks, his performance reduced to a point where he started to resent training and competing, and became uneven in the contact. Physical examination found the horse to be 2/5 lame in the left forelimb, with moderate swelling of the left intercarpal joint and resentment to flexion of the left knee. (continue)

 

Joint Lameness:

The lameness was isolated to the left intercarpal joint with a local anaesthetic, with subsequent radiographs showing sharp lucent bone modelling of the dorsodistal radiocarpal bone, as shown within the green circle in the image left. These changes indicate that osteoarthritis was present within this joint and causing performance-limiting lameness.

Treatment and Outcome: 

2ml of Arthramid® Vet was injected into the joint and the horse was then rested for 48 hours before commencing an ascending exercise program over two weeks to return to a full exercise regime. Over the space of four weeks, the clinical signs dissipated with the horse no longer showing lameness or resenting training. Elmo subsequently has been competing for 18 months since this initial diagnosis and medication of the joint, without recurrence of clinical signs.

Our Manufacturing Policy

Every detail is taken care of

We realised early on that quality assurance is everything when you need a product that an animal’s health and well-being relies on. We needed to know every step of the manufacturing process; to ensure the quality and integrity of our products. All materials are stored at a constant temperature and humidity to ensure consistency within manufacturers recommendations. We want to make sure every detail is taken care of in the best way possible and we only work with suppliers that hold the same values.

JOINT LAMENESS & OSTEOARTHRITIS

Osteoarthritis (OA) is considered one of the most important musculoskeletal disorders in both humans and horses.

CLINICAL SAFETY IN APPLICATION

Both in vitro and in vivo studies have taken place, of Arthramid Vet to support regulatory submissions for market authorisation.

Industry Changing Innovations

Integrity in every product

For professional athletes, both human and equine alike, banned substance testing carries fear for even those riders and trainers making every effort to stay compliant. We want to ensure the integrity of every product we recommend meets local racing and regulatory authority requirements with the finished product being extensively tested for quality, potency and banned substances.

Get In Touch

I am Interested In

Order Request

32 Hill Road, Cambridge, NZ
Phone +64 (09) 8013 253
E: sales@imsvet.com

Innovative Medical Solutions

Registered in New Zealand to: Innovative Medical Solutions Limited NZBN: 9429041325544, 32 Hill Road, Cambridge 3494, New Zealand. Registered pursuant to the ACVM Act 1997 Number A11596. See www.foodsafety.govt.nz  for registration conditions.

32 Hill Road, Cambridge
PO Box 1083, Cambridge 3450
Phone +64 (09) 8013 253
sales@imsvet.com